OncoSec Medical Incorporated reported earnings results for the full year ended July 31, 2022. For the full year, the company reported net loss was USD 34.18 million compared to USD 45.17 million a year ago. Basic loss per share from continuing operations was USD 19.14 compared to USD 30.14 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.67% | -99.67% | 0.00% |
2023 | Motion for Asset Sale Approved for OncoSec Medical Incorporated | CI |
2023 | Motion for Asset Sale Filed by OncoSec Medical Incorporated | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 5 | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- ONCS.Q Stock
- News OncoSec Medical Incorporated
- OncoSec Medical Incorporated Reports Earnings Results for the Full Year Ended July 31, 2022